Citigroup reiterated coverage on Galera Therapeutics with a new price target

12/20/21 9:46:24 AM ET

Biotechnology: Pharmaceutical Preparations

Health Care

Citigroup reiterated coverage of Galera Therapeutics with a rating of Buy and set a new price target of $20.00 from $11.00 previously

Save time and jump to the most important pieces.

Recent Analyst Ratings for
$GRTX

Date	Price Target	Rating	Analyst
8/10/2023	$6.00 → $0.50	Overweight → Neutral	Piper Sandler
12/20/2021	$11.00 → $20.00	Buy	Citigroup
12/15/2021	$10.00	Neutral → Buy	HC Wainwright & Co.
12/15/2021	$15.00	Neutral → Buy	BTIG
10/20/2021		Buy → Neutral	HC Wainwright & Co.
10/19/2021	$17.00 → $2.00	Buy → Underperform	BofA Securities
10/19/2021		Buy → Neutral	BTIG Research